Skip to main content
SUPPORT CANCER RESEARCH
INTRANET
IMTM PORTAL
IMTM
About us
Mission & vision
Management
Science advisory board
Supervisory board
IMTM advisory board
Certificates
Career & tenders
Media
Welcome info service
Technologies & services
Diagnostika [CZ]
Equipment
Clinical trials
Technologies
Research
Research programs
Laboratories and research groups
Core facilities
Publications
Product pipeline
Careers
Why the IMTM?
Undergraduate
Doctoral
Postdoctoral
Contact
General contacts
Staff
How to find us
Press release
Mission & Vision
Management
Supervisory Board
Science Advisory Board
IMTM Advisory Board
Certificates
Career & Tenders
Media
Press release
Media about us
Photo Gallery
Welcome info service
June 28, 2018
Nepřiměřená rychlost replikace DNA škodí nádorovým buňkám – olomoučtí vědci objevili nový mechanismu účinku léčiva olaparib, které se nyní dostává i k pacientkám v České republice (Czech language)
December 7, 2017
Lékem na alkoholismus proti rakovině – průlomový mechanismus objasněný- (Czech language)
March 6, 2017
(Bio)technologies of Czech scientists connected with global investors. They are coming to Prague.
February 26, 2016
Investments in biotechnology and medicine in the Czech Republic in the coming years will increase [in Czech]
April 4, 2015
How tumours bypass treatment with olaparib, a new drug for a hereditary form of ovarian cancer
April 4, 2015
How tumours bypass treatment with olaparib, a new drug for hereditary form of ovarian cancer [in Czech]
April 2, 2015
Esteemed scientist from Institute of Standards and Technology in Gaithersburg (US) Dr. Wyatt N. Vreeland visited University of Palacky
December 9, 2014
Global Collaboration Initiation - EATRIS
November 10, 2014
IMTM looking for promising researchers in Malaysia
October 16, 2014
CPhI 2014 PARIS
Pages
1
2
next ›
last »